Skip to content
★ Sign in to follow
RT

Raymond T. Keane

Directeur Juridique
Cullinan Therapeutics, Inc.Ariad Pharmaceuticals Inc
Total declarations
30
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (14 ops.)
€1.6M

Latest filing published 15 Feb 2022 for Cullinan Therapeutics, Inc..

Insider track record

Disclosed buys
0
Disclosed sells
14
Signal history

No signal scores available.

Raymond T. Keane: trading record in brief

This profile gathers the share dealings of Raymond T. Keane across 2 companies, led by Ariad Pharmaceuticals Inc and Cullinan Therapeutics, Inc. Between 17 May 2010 and 11 February 2022, the trades on record add up to 30 filings.

On the market, this insider has only sold: 14 sales, €1.6M in total. Besides market trades, the filings include 3 share grants and 13 option exercises.

The record was last updated on 15 February 2022 with a share grant in Cullinan Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Raymond T. Keane

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations30 total

25 of 30 declarations